Stage IV malignant transformation of mature cystic teratoma palliatively treated with concurrent chemoradiotherapy: A case report

Table 1 Summary of patients with malignant transformation of mature cystic teratomas who received concurrent chemoradiotherapy

Ref.	Age	Stage	Surgery	Adjuvant therapy	Follow-up (months)	Outcome
Rose et al[3], 1993	42	III C	RSO, retroperitoneal dissection, PAN	CCRT (cisplatin)	11	DOD
Do et al[4], 2001	44	II B	LSO	CCRT (5-FU, leucovorin)	36	NED
Park et al[5], 2008	43	III C	PLN, PAN, total omentectomy, Appe	CCRT, TP	13	NED
Yoshida et al[6], 2016	37	II B	TAH, BSO	CCRT (cisplatin, 5-FU)	27	NED
Tokunaga et al[7], 2016	49	III A	TAH, BSO, pOM, PLN, PAN	CCRT	?	NED
Tokunaga et al[7], 2016	40	III C	TAH, BSO, pOM, PLN, PAN	CCRT	?	NED
Bacalbasa et al[8], 2020	47	I A	TAH, LSO	CCRT (cisplatin)	24	NED

Appe: Appendectomy; BSO: Bilateral salpingo-oophorectomy; DOD: Died of disease; LSO: Left salpingo-oophorectomy; NED: No evidence of disease; Pom: Partial omentectomy; PLN: Pelvic lymphadenectomy; PAN: Para-aortic lymphadenectomy; TAH: Total abdominal hysterectomy; TP: Paclitaxel, cisplatin; CCRT: Concurrent chemoradiotherapy.